6TCS
Crystal structure of the omalizumab scFv
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | DIAMOND BEAMLINE I24 |
Synchrotron site | Diamond |
Beamline | I24 |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2014-02-01 |
Detector | DECTRIS PILATUS 6M |
Wavelength(s) | 0.9686 |
Spacegroup name | P 31 2 1 |
Unit cell lengths | 73.909, 73.909, 117.763 |
Unit cell angles | 90.00, 90.00, 120.00 |
Refinement procedure
Resolution | 56.237 - 2.300 |
R-factor | 0.1794 |
Rwork | 0.178 |
R-free | 0.20620 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 6tcm |
RMSD bond length | 0.004 |
RMSD bond angle | 0.683 |
Data reduction software | XDS |
Data scaling software | Aimless |
Phasing software | PHASER |
Refinement software | PHENIX (1.10_2155) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 64.010 | 2.380 |
High resolution limit [Å] | 2.300 | 2.300 |
Rmerge | 0.259 | 2.248 |
Rpim | 0.121 | 1.064 |
Number of reflections | 17055 | 1655 |
<I/σ(I)> | 6.2 | 2.5 |
Completeness [%] | 99.8 | 99.9 |
Redundancy | 5.5 | 5.2 |
CC(1/2) | 0.974 | 0.597 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 5.6 | 291 | 0.1M tri-sodium citrate pH5.6, 15% PEG 4000 and 0.2M ammonium sulphate. Crystals were cryoprotected with 0.1M tri-sodium citrate pH5.6, 30% PEG 4000 and 0.2M ammonium sulphate |